Skip to main content

FACULTY

Executive Committee

Dr. Siavash Atrchian

Radiation Oncologist, BC Cancer, Kelowna, BC

Siavash Atrchian, MD, FRCPC

Clinical Assistant Professor, Division of Radiation Oncology and Developmental Radiotherapeutics, UBC Department of Surgery, Radiation Oncologist, BC Cancer, Kelowna, BC

Dr. Siavash Atrchian is a Radiation Oncologist at BC Cancer Kelowna and a Clinical Assistant Professor in the Faculty of Medicine at the University of British Columbia. Dr. Atrchian specializes in Lung, Breast and Gastrointestinal tumor sites, with a special interest in Stereotactic Ablative Radiotherapy(SABR). He is the principal investigator and co-principal investigator of multiple current research studies. His research interests include: Deep Learning Applications in Radiation Oncology, SABR, Outcomes of Cancer Treatment and the role of Microbiome in cancer development.
https://surgery.med.ubc.ca/people/s-atrchian/

Dr. Siavash Atrchian,
Radiation Oncologist,
BC Cancer, Kelowna, BC

Dr. Houda Bahig

Radiation Oncologist, CHUM, Montreal, QC

Houda Bahig, MDCM, PH.D.

Associate Professor, Department of Radiology, Radiation Oncology & Nuclear Medicine, Université de Montréal, Radiation Oncologist, CHUM, Montreal, QC

Dr Bahig specializes in the treatment of head and neck cancers and lung cancers, with a special interest for the development of pragmatic clinical trials evaluating new technological approaches to individualize radiotherapy. She also works on the development of algorithms using artificial intelligence to predict the response and side effects of head and neck, and thoracic radiotherapy.

Dr. Houda Bahig,
Radiation Oncologist,
CHUM, Montreal, QC

Dr. Alanah Bergman

Senior Medical Physicist, BC Cancer, Vancouver, BC

Dr. Bergman is a senior medical physicist at BC Cancer - Vancouver and Fellow of the Canadian College of Physicists in Medicine. She has been in the thick of the rapid expansion of the stereotactic body radiotherapy (SABR) program at BC Cancer. She has seen the Vancouver program grow from 14 lung SABR patients in 2009 to an extensive multi-site program, treating over 300 SABR patients/year. Alanah has been super excited to have BC Cancer participate in several landmark Canadian-led SABR Trials. Her interests currently lie with motion management for lung and liver SABR and she is the lead physicist for the BC Cancer Dynamic Tumour Tracking program. Her current work includes expanding the fiducial-based Liver SABR tracking program and implementing a fiducial-LESS tracking program for Lung and Liver. She is also interested in re-treatment planning workflows, particularly in the SABR context.

Dr. Alanah Bergman,
Senior Medical Physicist,
BC Cancer, Vancouver, BC

Mr. Michael Darud

Director of Operations Oncologist, BC Cancer, Kelowna, BC

Mr. Michael Darud,
Director of Operations,
BC Cancer, Kelowna, BC

Dr. Laura Dawson

Radiation Oncologist, PMH, Toronto, ON

Laura Dawson, MD, FRCPC, FASTRO

Professor, Department of Radiation Oncology, University of Toronto, Radiation Oncologist, PMH, Toronto, ON

Dr. Laura Dawson is a Professor in the Department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist at the Radiation Medicine Program, Princess Margaret Cancer Centre, in Toronto. She is the multi-disciplinary hepatobiliary cancer and pancreatic cancer site lead for the Princess Margaret Cancer Committee. She is an internationally recognized leader in hepatocellular carcinoma and in oligo-metastases stereotactic body radiation therapy (SBRT). She is the principal investigator of two randomized phase III clinical trials investigating the use of radiation therapy in hepatocellular carcinoma (RTOG1112 and CCTG HE1).

Dr. Laura Dawson,
Radiation Oncologist,
PMH, Toronto, ON

Dr. Alexander Louie

Radiation Oncologist, Sunnybrook, Toronto, ON

Dr. Alexander Louie, MD, PhD, M.Sc., FRCPC

Dr. Louie’s academic focus is the use of comparative effectiveness research in lung, kidney and oligometastatic cancers. He has expertise in clinical trials, patient-reported outcomes, population databases, decision analyses, health economics and technological appraisals.

Dr. Alex Louie,
Radiation Oncologist,
Sunnybrook, Toronto, ON

Dr. Benjamin Mou

Radiation Oncologist, BC Cancer, Kelowna, BC

Benjamin Mou, MD, FRCPC

Clinical Assistant Professor, University of British Columbia, Radiation Oncologist, BC Cancer, Kelowna, BC

Dr. Mou is a radiation oncologist at BC Cancer Kelowna and clinical assistant professor at the University of British Columbia. He is the chair of the Stereotactic and Lung Technical Site Teams in Kelowna and the Chair of the Provincial Lung Radiation Oncology Group in BC. He specializes in SABR and radiosurgery for multiple body sites with a particular interest in Lung, CNS, and GI malignancies. He serves as the site principal investigator in Kelowna for multiple SABR clinical trials and is involved provincially in the clinical implementation and advancement of lung and spine SABR in BC.

Dr. Ben Mou,
Radiation Oncologist,
BC Cancer, Kelowna, BC

Moderators

Dr. Robert Olson

Radiation Oncologist, BC Cancer, Prince George, BC

Robert Olson, MD, FRCPC, MSc

Rob Olson is a Radiation Oncologist and researcher who practices in BC Cancer - Prince George. He is the Division Head of Radiation Oncology and the Associate Head of Research in the Department of Surgery, both at UBC. His primary research focus is on SABR in the setting of metastatic disease, and is the principal investigator on several SABR clinical trials, including SABR-5 and SABR-COMET-3.

Robert Olson
Radiation Oncologist,
BC Cancer, Prince George, BC

Dr. Devin Schellenberg

Radiation Oncologist, BC Cancer, Surrey, BC

Devin Schellenberg, BSc MD FRCPC

Clinical Associate Professor, University of British Columbia, Department Head of Radiation Oncology, BC Cancer Surrey Centre, Radiation Oncologist, BC Cancer, Surrey, BC

Dr. Devin Schellenberg completed medical school and Residency at the University of BC and University of Toronto. He went onto a Fellowship at Stanford University and has been the Department Head of Radiation Oncology at the BC Cancer Surrey Centre for the past 4 years. He chairs the Lung Radiation Oncology working group with CCTG and is a founding member of CAPRI (Canadian Pulmonary Radiotherapy Investigators Group).
He has been a leader in BC Cancer’s Stereotactic Ablative Body Radiotherapy (SABR) programs and his current research efforts focus on how radiation can alter the course of metastatic disease and (outside of cancer) whether radiation is able to treat heart arrhythmias.

Dr. Devin Schellenberg,
Radiation Oncologist,
BC Cancer, Surrey, BC